MarketPeel
Insider Trading Intelligence
Pricing
…
TH

Todd Hornsby

APYX
EXECUTIVE VICE PRESIDENT · APYX MEDICAL CORP · CIK 0001764505
FILING MIX · LIFETIME64%/36%
BUYS
7
SELLS
4
TOTAL VALUE
$279.9K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
0
AVG SELL PX
$7.56
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Todd Hornsby, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-29.93%+2.86%-32.80%-32.80%—
14d1+100.00%-30.46%+1.91%-32.37%-32.37%—
30d1+100.00%-35.50%+5.58%-41.08%-41.08%—
60d1+100.00%-43.05%+1.98%-45.02%-45.02%—
90d1+100.00%-58.28%+0.54%-58.81%-58.81%—
180d1+100.00%-66.49%+10.62%-77.11%-77.11%—
1y1+100.00%-81.46%+28.05%-109.50%-109.50%—
2y1+100.00%-74.83%+44.04%-118.87%-118.87%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APYX · 0 shares · as of Jan 10, 2024
025,00050,00075,000100,0002021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
FLOW · 7 buys / 4 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
100,000——0Jan 10, 2024Jan 11, 2024 ↗View →
APYX
APYX MEDICAL CORP
SALE10b5-1
10b5-1 plan
15,000$7.56$113.4K0Jun 26, 2023Jun 29, 2023 ↗View →
APYX
APYX MEDICAL CORP
SALE
Executive Vice President
15,000——20,000Jun 26, 2023Jun 29, 2023 ↗View →
APYX
APYX MEDICAL CORP
PURCHASE
Executive Vice President
15,000$1.77$26.6K15,000Jun 26, 2023Jun 29, 2023 ↗View →
APYX
APYX MEDICAL CORP
PURCHASE
Executive Vice President
15,000$1.77$26.6K15,000Jun 26, 2023Jun 28, 2023 ↗View →
APYX
APYX MEDICAL CORP
SALE10b5-1
10b5-1 plan
15,000$7.56$113.4K40Jun 26, 2023Jun 28, 2023 ↗View →
APYX
APYX MEDICAL CORP
SALE
Executive Vice President
15,000——0Jun 26, 2023Jun 28, 2023 ↗View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
100,000——100,000Jan 11, 2023Jan 13, 2023 ↗View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
100,000——100,000Jan 19, 2022Jan 30, 2022 ↗View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
50,000——50,000Jan 29, 2021Feb 8, 2021 ↗View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
100,000——100,000Jan 15, 2020Jan 15, 2020 ↗View →
Other insiders · APYX
Loading peer insiders…
About this filer
CIK 0001764505
ROLE
Executive Vice President
PRIMARY
APYX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001764505DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback